Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
Warner-admin (talk | contribs) m (Text replacement - "/CD3 bispecific" to "-CD3 bispecific") |
||
| (One intermediate revision by one other user not shown) | |||
| Line 10: | Line 10: | ||
[[Category:T-cell activators]] | [[Category:T-cell activators]] | ||
| − | [[Category:Anti-CD33 | + | [[Category:Anti-CD33-CD3 bispecific antibodies]] |
| − | |||
[[Category:Investigational drugs]] | [[Category:Investigational drugs]] | ||
Latest revision as of 00:14, 18 October 2023
Mechanism of action
Bispecific T-cell engager antibody that engages CD33 and CD3
Also known as
- Code name: AMG-330